Erika B-Cure Laser Ltd (TLV:BCUR)

-49.27% (1Y)

Market Cap	21.77M
Revenue (ttm)	32.88M
Net Income (ttm)	-9.85M
Shares Out	104.17M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	816
Average Volume	17,716
Open	21.00
Previous Close	20.90
Day's Range	20.90 - 21.00
52-Week Range	16.90 - 45.00
Beta	1.48
RSI	37.66
Earnings Date	Mar 30, 2025

About Erika B-Cure Laser

Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 40
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BCUR

Financial Performance

In 2023, Erika B-Cure Laser's revenue was 29.88 million, a decrease of -40.62% compared to the previous year's 50.32 million. Losses were -19.22 million, -40.97% less than in 2022.